Interleukin 12 - Mural Oncology
Alternative Names: IL-12 - Mural Oncology; Interleukin-12 - Mural OncologyLatest Information Update: 15 Apr 2024
At a glance
- Originator Alkermes plc
- Developer Mural Oncology
- Class Antineoplastics; Immunotherapies; Interleukins
- Mechanism of Action Interleukin 12 replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer